LBX Pharmacy Chain Joint Stock Company (SHA:603883)

China flag China · Delayed Price · Currency is CNY
16.56
+0.04 (0.24%)
Oct 10, 2025, 3:00 PM CST

SHA:603883 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Operating Revenue
22,02822,21322,28820,05515,57913,867
Upgrade
Other Revenue
164.49144.48149.26120.29117.1199.9
Upgrade
22,19222,35822,43720,17615,69613,967
Upgrade
Revenue Growth (YoY)
-1.66%-0.36%11.21%28.54%12.38%19.75%
Upgrade
Cost of Revenue
14,97314,94615,15713,75110,6599,506
Upgrade
Gross Profit
7,2197,4127,2806,4255,0374,461
Upgrade
Selling, General & Admin
6,1386,2055,7535,0053,9903,483
Upgrade
Research & Development
38.492.012.512.23-0.15
Upgrade
Other Operating Expenses
48.7333.6846.2138.5114.9543.66
Upgrade
Operating Expenses
6,2276,2475,8115,0534,0103,536
Upgrade
Operating Income
991.641,1651,4691,3711,027924.58
Upgrade
Interest Expense
-157.96-178.25-185.6-232.14-192.13-58.49
Upgrade
Interest & Investment Income
20.8822.8393.8751.3537.1420.77
Upgrade
Currency Exchange Gain (Loss)
--1.25-5.22-16.914.8-
Upgrade
Other Non Operating Income (Expenses)
-10.84-13.65-14.61-13.4-14.44-27.93
Upgrade
EBT Excluding Unusual Items
843.72994.51,3571,160861.9858.93
Upgrade
Impairment of Goodwill
-107.54-107.54----
Upgrade
Gain (Loss) on Sale of Investments
1.5--1.55.7710.47-
Upgrade
Gain (Loss) on Sale of Assets
-6.86-4.535.511.444.66-1.43
Upgrade
Other Unusual Items
54.3833.5446.6940.2184.9599.37
Upgrade
Pretax Income
785.2915.971,4081,208961.99956.86
Upgrade
Income Tax Expense
211.99230.85284.27231.37175.26192.38
Upgrade
Earnings From Continuing Operations
573.22685.121,124976.24786.73764.48
Upgrade
Minority Interest in Earnings
-158.99-166.05-194.54-191.28-117.49-143.39
Upgrade
Net Income
414.22519.06929.02784.96669.24621.09
Upgrade
Net Income to Common
414.22519.06929.02784.96669.24621.09
Upgrade
Net Income Growth
-54.90%-44.13%18.35%17.29%7.75%22.09%
Upgrade
Shares Outstanding (Basic)
765763755750707682
Upgrade
Shares Outstanding (Diluted)
765763755750707691
Upgrade
Shares Change (YoY)
0.83%1.06%0.67%6.08%2.42%1.21%
Upgrade
EPS (Basic)
0.540.681.231.050.950.91
Upgrade
EPS (Diluted)
0.540.681.231.050.950.90
Upgrade
EPS Growth
-55.27%-44.71%17.57%10.57%5.20%20.63%
Upgrade
Free Cash Flow
2,5681,5192,1092,0061,8201,053
Upgrade
Free Cash Flow Per Share
3.361.992.792.672.571.52
Upgrade
Dividend Per Share
0.0800.4110.5080.3850.2960.207
Upgrade
Dividend Growth
-90.46%-19.11%32.01%30.02%42.83%16.68%
Upgrade
Gross Margin
32.53%33.15%32.45%31.84%32.09%31.94%
Upgrade
Operating Margin
4.47%5.21%6.55%6.80%6.54%6.62%
Upgrade
Profit Margin
1.87%2.32%4.14%3.89%4.26%4.45%
Upgrade
Free Cash Flow Margin
11.57%6.79%9.40%9.94%11.59%7.54%
Upgrade
EBITDA
1,1931,3451,6621,5331,1621,037
Upgrade
EBITDA Margin
5.37%6.01%7.41%7.60%7.41%7.42%
Upgrade
D&A For EBITDA
200.99179.84193.69161.87135.67112.02
Upgrade
EBIT
991.641,1651,4691,3711,027924.58
Upgrade
EBIT Margin
4.47%5.21%6.55%6.80%6.54%6.62%
Upgrade
Effective Tax Rate
27.00%25.20%20.19%19.16%18.22%20.11%
Upgrade
Revenue as Reported
22,19222,35822,43720,17615,69613,967
Upgrade
Advertising Expenses
-115.57117.9994.5109.84103.68
Upgrade
Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.